Can antibody prophylaxis allow sparing of other immunosuppressives?

被引：43

作者：

Vincenti, F

Grinyo, J

Ramos, E

Nashan, B

Stuart, F

Kuypers, D

Brattstrom, C

Cho, S

Ekberg, H

Johnson, R

机构：

[1] Univ Calif San Francisco, Kidney Transplant Serv, San Francisco, CA 94143 USA

[2] Bellvitge Hosp, Barcelona, Spain

[3] Roche Global Dev, Palo Alto, CA USA

[4] Hannover Med Sch, Hannover, Germany

[5] Northwestern Univ, Chicago, IL 60611 USA

[6] Univ Hosp Gasthuisberg, Leuven, Belgium

[7] Karolinska Inst, Huddinge, Sweden

[8] Boston Med Ctr, Boston, MA USA

[9] Malmo Univ Hosp, Malmo, Sweden

[10] Manchester Royal Infirm, Manchester M13 9WL, Lancs, England

来源：

TRANSPLANTATION PROCEEDINGS | 1999年 / 31卷 / 1-2期

关键词：

D O I：

10.1016/S0041-1345(98)01982-4

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1246 / 1248

页数：3

共 7 条

[1] Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy [J].

Bennett, WM ;

DeMattos, A ;

Meyer, MM ;

Andoh, T ;

Barry, JM .

KIDNEY INTERNATIONAL, 1996, 50 (04) :1089-1100

[2]

GRINYO JM, 1997, INT C IMM ORL FLOR D

[3] Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients [J].

Nashan, B ;

Moore, R ;

Amlot, P ;

Schmidt, AG ;

Abeywickrama, K ;

Soulillou, JP .

LANCET, 1997, 350 (9086) :1193-1198

[4]

NASHAN B, IN PRESS TRANSPLANTA

[5]

NASHAN B, 1998, AM SOC TRANSPL PHYS

[6]

SOLEZ K, IN PRESS TRANSPLANTA

[7] Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation [J].

Vincenti, F ;

Kirkman, R ;

Light, S ;

Bumgardner, G ;

Pescovitz, M ;

Halloran, P ;

Neylan, J ;

Wilkinson, A ;

Ekberg, H ;

Gaston, R ;

Backman, L ;

Burdick, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (03) :161-165

← 1 →